Asporto Launched at the International Heart and Lung Transplantation Conference April 2018- The new Asporto // Heart Preservation Device by Hibernicor was launched on April 11th,2018 at the International Heart and Lung Transplant Conference in Nice (Fr).  The conference had 2665 attendees from over 45 countries who specialize in the multidisciplinary management and treatment of end-stage heart and lung disease. Hibernicor completed the initial production of a light-weight carbon […]
Hibernicor Selected as Finalist for Boston Pediatric Device Strategic Partner Challenge November 2017- Hibernicor has been selected as a finalist for the Boston Pediatric Device Consortium Strategic Partner Challenge after a comprehensive review of applications conducted by the Boston Pediatric Device Consortium (BPDC), the Innovation & Digital Health Accelerator at Boston Children’s Hospital (IDHA), and partner organizations. Date/Time: Wednesday, December 6th, 8:00 am – 6:00 pm Location: 300 […]
Hibernicor Announces Upgrade to the Asporto Software September 2017- The Asporto // Heart Preservation Device is a portable thermoelectric cooler for transporting the donor heart to heart transplant recipients.  The device consists of a microcontroller with touch-screen display, insulated container, peristaltic pump, AC to DC converter and a sterile disposable kit. The Asporto microcontroller has been upgraded to software version 5.02.  The completely new software allows the microcontroller to […]
Semi-finalist – 2009 Minnesota Cup business plan competition June 2009- With over 1000 entries to the 2009 Minnesota Cup, Hibernicor ranked in the Top 10  in the Biosciences category following a first round of judging.  The Minnesota Cup is an annual, statewide competition, which seeks out aspiring entrepreneurs and their breakthrough ideas.  The competition was hosted by the University of Minnesota and Wells Fargo for its fifth year.  
Hibernicor begins discussions with the FDA on the pre-clinical research protocol October 2008- Hibernicor met with representatives of FDA’s Center for Devices and Radiologic Health (CDRH) on October 30th, 2008.  Based upon the discussions with the FDA, Hibernicor has finalized the pre-clnical research protocol necessary for 510k approval.
Research study shows that Asporto limits degradation of the donor heart May 2008- A recent study from the University of Minnesota using the Asporto heart preservation device was published in a nationally recognized peer reviewed journal. The study demonstrated that intermittent antegrade cardioplegia maintains a significantly higher pH in donor hearts. The study involved a series of animal hearts preserved using the conventional method of donor heart transportation […]
Praesto software installed at the University of Minnesota August 2007- The electronic research record Praesto was implemented this month at the University of Minnesota’s Experimental Surgical Services. Richard W. Bianco, the GLP laboratory’s director was extremely satisfied with the conversion to the electronic format that will be used initially in the preclinical testing of new heart valves.
Asporto featured at the 27th Annual Meeting of the International Society for Heart and Lung Transplantation April 2007- Research completed at the University of Minnesota was presented at the 27th Annual Meeting of the International Society for Heart Lung Transplant. The study demonstrated the effectiveness of intermittent antegrade cardioplegia in reducing damage during prolonged storage of isolated heart.
Winner – University of St. Thomas business plan competition December 2006- On December 12th, 2006, the University of Thomas Schulze School of Entrepreneurship held its semiannual business plan competition.  Jordan Milan of Hibernicor, LLC was awarded first place for her presentation outlining the startup company to a panel of judges.
Hibernicor featured in Twin Cities Business Magazine November 2006- Andrew Rivard, a research consultant at the University of Minnesota’s Department of Surgery and a resident physician at the Unversity of Florida, believes he has a better way to deliver donor hearts.  Traditionally this has been performed via a basic handheld cooler. However, Rivard says this method has a key limitation…
Semi-finalist – 2006 Minnesota Cup business plan competition September 2006- With over 650 entries to the 2006 Minnesota Cup, Hibernicor ranked in the Top 10 following a second round of judging. The Minnesota Cup is an annual, statewide competition, which seeks out aspiring entrepreneurs and their breakthrough ideas. The competition was hosted by the University of Minnesota and Wells Fargo for its second year.
Hibernicor featured in the New Technology Showcase at the Medical Alley (now LifeScience Alley) 2005 Conference October 2005- Together, Hibernicor and Minnetronix successfully launched the prototype heart preservation device as one of eight companies selected to participate in the New Technology Showcase at the Medical Alley Annual Conference & Expo, October 5 & 6, 2005 (now known as Medical Alley Association ).
First preclinical heart transplant August 2005- In a Minnesota Medical Foundation funded study, Dr. Ranjit John transplanted the first porcine hearts stored in a prototype heart preservation device at the University of Minnesota, Experimental Surgical Services. The study successfully demonstrated the feasiblity of system as it was designed for extended heart preservation.